Contact us
Innovation
Company
Therapeutic areas
Investors
News
Career
Contact
Verigraft
Arvid Wallgrens Backe 20
41346 Gothenburg
Sweden
info@verigraft.com
Home
/
News
/
VERIGRAFT reports promising interim…
News
Published: October 9, 2023
VERIGRAFT reports promising interim results from a first-in-man study in patients with deep venous insufficiency at 2023 Cell & Gene Meeting on the Mesa
Link to the article
Latest news
See all news
Published: March 4, 2025
Testimonial by Fredrik Wessberg, CFO att CCRM Nordic
Published: February 25, 2025
Exclusive Investment Opportunity in VERIGRAFT – Online Webinar, March 5th
Published: February 24, 2025
VERIGRAFT at the American Venous Forum 2025
Published: February 19, 2025
VERIGRAFT at the Embassy of Sweden in Madrid
Published: February 18, 2025
Collaboration between VERIGRAFT and Chalmers University of Technology
Published: February 14, 2025
Global recognition for VERIGRAFT and P-TEV